Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1132 of 1,261
  1. US 6897305

    Calcium channel drugs and uses

    Theravance, Inc. Β· Granted May 24, 2005 Β· Expires May 19, 2025

    expired
  2. US 6897316

    Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents

    China Medical University Β· Granted May 24, 2005 Β· Expires May 19, 2025

    expired
  3. US 6896909

    Formulations containing iron ores for the topical treatment of bioenergetic and electromagnetic disorders

    WINMEDICAL S.R.L. Β· Granted May 24, 2005 Β· Expires May 19, 2025

    expired
  4. US 6894027

    Stimulation of bone growth with thrombin peptide derivatives

    The Board of Regents of the University of Texas System Β· Granted May 17, 2005 Β· Expires May 12, 2025

    expired
  5. US 6893643

    Recombinant yellow fever virus and methods of use thereof

    The Regents of the University of California Β· Granted May 17, 2005 Β· Expires May 12, 2025

    expired
  6. US 6893869

    Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted May 17, 2005 Β· Expires May 12, 2025

    expired
  7. US 6894026

    Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders

    Atossa Healthcare, Inc. Β· Granted May 17, 2005 Β· Expires May 12, 2025

    expired
  8. US 6893821

    Agents that modulate DNA-PK activity and methods of use thereof

    The Regents of the University of California Β· Granted May 17, 2005 Β· Expires May 12, 2025

    expired
  9. US 6893633

    Methods and compositions for promoting the maturation of monocytes

    Maxim Pharmaceuticals, Inc. Β· Granted May 17, 2005 Β· Expires May 12, 2025

    expired
  10. US 6894025

    Biologically active molecules having thiol moiety conjugated to polymers containing ethyl sulfone moiety

    Nektar Therapeutics AL, Corporation Β· Granted May 17, 2005 Β· Expires May 12, 2025

    expired
  11. US 6894069

    Method for treating perinatal asphyxia in a human or animal neonate

    Universitair Medisch Centrum Β· Granted May 17, 2005 Β· Expires May 12, 2025

    expired
  12. US 6894149

    Anti-HLA-DA antibodies and the methods of using thereof

    Protein Design Labs, Inc. Β· Granted May 17, 2005 Β· Expires May 12, 2025

    expired
  13. US 6894068

    Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted May 17, 2005 Β· Expires May 12, 2025

    expired
  14. US 6894154

    hKIS compositions and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted May 17, 2005 Β· Expires May 12, 2025

    expired
  15. US 6890917

    Geldanamycin derivative and method of treating cancer using same

    The United States of America, as represented by the Department of Health and Human Services Β· Granted May 10, 2005 Β· Expires May 5, 2025

    expired
  16. US 6890738

    Prolactin antagonists and uses thereof

    The Regents of the University of California Β· Granted May 10, 2005 Β· Expires May 5, 2025

    expired
  17. US 6890721

    Interleukin-1Ξ² converting enzyme like apoptotic protease-6

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted May 10, 2005 Β· Expires May 5, 2025

    expired
  18. US 6890552

    Manufacturing therapeutic enclosures

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted May 10, 2005 Β· Expires May 5, 2025

    expired
  19. US 6890537

    Antimicrobial theta defensins and methods of using same

    The Regents of the University of California Β· Granted May 10, 2005 Β· Expires May 5, 2025

    expired
  20. US 6890949

    Amino ceramide-like compounds and therapeutic methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted May 10, 2005 Β· Expires May 5, 2025

    expired
  21. US 6890311

    Methods for performing medical procedures within a breast duct

    The Regents of the University of California Β· Granted May 10, 2005 Β· Expires May 5, 2025

    expired
  22. US 6891989

    Optical switch systems using waveguide grating-based wavelength selective switch modules

    Integrated Optics Communications Corp. Β· Granted May 10, 2005 Β· Expires May 5, 2025

    expired
  23. US 6890518

    Compositions of chemically modified insulin

    Nektar Therapeutics Β· Granted May 10, 2005 Β· Expires May 5, 2025

    expired
  24. EP 1527086

    VERBINDUNGEN DIE P-SELECTIN BINDEN

    YAMANOUCHI EUROP BV [NL] Β· Granted May 4, 2005 Β· Expires Apr 29, 2025

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.